PlexusDx providers often hold a dose steady for an extra week, reduce the escalation increment, or switch formulations (injection to oral, for example) to find your comfort zone
In patients with such defects, the neutrophil chemotaxis and killing ability are decreased, making them prone to recurrent infections (Puel et al., 2012)
By week four, more noticeable effects typically emerge
Clinical Standards and Safety: Use of medical grade IV solutions and sterile equipment ensures the highest standard of patient care and safety
Perfect for maintaining privacy
Over 68 weeks in the REDEFINE trials, cagrilintide 2.4 mg alone achieved approximately 10.8% body weight reduction